The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs

Abstract

Early detection of malignant melanoma remains the key factor in lowering mortality from this cancer. Recognizing the importance of this issue 25 years ago, our group at New York University published in CA: A Cancer Journal for Clinicians the mnemonic "ABCD" to facilitate the early diagnosis of melanoma. Studies have demonstrated the usefulness of this paradigm in enhancing early melanoma diagnosis as a part of clinical examinations, mass screenings, and public education programs. Approaches to melanoma diagnosis have dynamically evolved during the ensuing quarter century. In the 1990s, dermoscopy enabled the recognition of new subsurface features to differentiate between malignant and benign pigmented lesions. During the last decade, new computer-based technologies have improved diagnostic sensitivity and specificity and may result in optimizing lesion selection for biopsy and pathology review. Despite all of the advances in melanoma diagnosis, timely recognition, detection, and rapid treatment of melanoma remain critical. Although pathologic examination remains the gold standard for diagnosis, this cancer has the potential to be diagnosed through noninvasive approaches because of its cutaneous location. From the development of the ABCDs through current attempts that use complex computer algorithms and genetic markers, a clinician's ability to detect melanoma in its earliest form has been augmented. However, a "good clinical eye" is still fundamental to selecting the lesions for evaluation among the sea of those that are prevalent. As current approaches are refined and new techniques are developed, the improved ability to diagnose this cancer will hopefully enhance reaching the goal of reducing melanoma mortality. CA Cancer J Clin 2010;60:301-316.

ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease

“…Th ere have been no randomized trials performed in patients with IBD assessing this recommendation; however, early detection, including performing regular skin self-examinations and physician skin examinations has been found to result in melanoma diagnoses at earlier stages, when the disease is most treatable ( 120,121 ). Th us, it is suggested that all IBD patients should follow a program of sun protection and dermatological surveillance, which takes into account their other non-IBD-related risk factors for skin cancer development ( 122,123 ). In addition, education on skin cancer risk and rapid referral for skin abnormalities is appropriate in this patient population.…”

A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

“…Melanoma is currently the fifth most frequently diagnosed cancer in the United States and is predicted to account for B65% of all skin cancer deaths in 2010 (Rigel et al, 2010). Melanoma metastases can occur early in the course of disease; therefore, detecting melanoma early is critical for patient survival (Rigel et al, 2010).…”

“…Melanoma metastases can occur early in the course of disease; therefore, detecting melanoma early is critical for patient survival (Rigel et al, 2010). Beyond an early surgical removal of the primary tumor, there is currently no highly effective standard therapy available, especially for more advanced stages (Segura et al, 2010).…”

Design and characterization of a novel multimodal fiber-optic probe and spectroscopy system for skin cancer applications

“…Currently, the only reliable method of distinguishing between dysplastic nevi and melanoma is via stained biopsies, which is invasive and expensive. Clinician specificity for melanoma is approximately 4%, 23,24 which means that roughly 25 more times biopsies are performed than required, translating to an estimated cost of $6 × 10 9 to the US health care system. In 2007, the mean wait time for new patients in urban areas to see a dermatologist was 33 days; in rural areas, the number rises to 46 days.…”